DCAI
CAS No. 299165-92-7
DCAI( —— )
Catalog No. M27763 CAS No. 299165-92-7
DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 10MG | 318 | In Stock |
|
| 25MG | 535 | In Stock |
|
| 50MG | 736 | In Stock |
|
| 100MG | 1042 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2093 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDCAI
-
NoteResearch use only, not for human use.
-
Brief DescriptionDCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
-
DescriptionDCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptormTOR (FKBP12)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number299165-92-7
-
Formula Weight243.13
-
Molecular FormulaC11H12Cl2N2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1[nH]c2cc(Cl)cc(Cl)c2c1CCN
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Maria Raffaella Martina, et al. The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands. J Med Chem. 2013 Feb 14;56(3):1041-51.
molnova catalog
related products
-
GW604714X?
GW604714X were found to be potent inhibitors of mitochondrial respiration supported by pyruvate.
-
Myristoylated ADP - ...
Myristoylated ADP - Ribosylation Factor 1, myr - ARF1 (2 - 17)
-
PTD-p65-P1 Peptide
PTD-p65-P1 Peptide is a nuclear transcription factor NF-kappaB inhibitor, composed of a membrane-translocating peptide sequence generated from antennapedia (PTD) conjugated with p65-P1, which selectively inhibits activation induced by various inflammatory stimuli. PTD-p65-P1 suppressed NF-kappaB activation induced by lipopolysaccharide, interleukin-1, okadaic acid, phorbol 12-myristate 13-acetate, H(2)O(2), and cigarette smoke condensate as well as that induced by TNF.
Cart
sales@molnova.com